Literature DB >> 12755488

Profiling breast cancer by array CGH.

Donna G Albertson1.   

Abstract

Breast tumors display a wide variety of genomic alterations. This review focuses on DNA copy number variations in these tumors as measured by the recently developed microarray-based form of comparative genomic hybridization. The capabilities of this new technology are reviewed. Initial applications of array CGH to the analysis of breast cancer, and the mechanisms by which the particular types of copy number changes might arise are discussed.

Entities:  

Mesh：

Year:  2003        PMID： 12755488     DOI： 10.1023/a:1023025506386

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN： 0167-6806            Impact factor:   4.872


  26 in total

1.  Limited tissue fixation times and whole genomic amplification do not impact array CGH profiles.

Authors:  A A Ghazani; N C R Arneson; K Warren; S J Done
Journal:  J Clin Pathol       Date:  2006-03       Impact factor: 3.411

2.  Overexpression of Cks1 is associated with poor survival by inhibiting apoptosis in breast cancer.

Authors:  Xiao-Chun Wang; Li-Li Tian; Jing Tian; Hai-Liang Wu; Ai-Min Meng
Journal:  J Cancer Res Clin Oncol       Date:  2009-04-08       Impact factor: 4.553

3.  The cytochrome P450 enzyme CYP24A1 increases proliferation of mutant KRAS-dependent lung adenocarcinoma independent of its catalytic activity.

Authors:  Wei Huang; Paramita Ray; Wenbin Ji; Zhuwen Wang; Derek Nancarrow; Guoan Chen; Stefanie Galbán; Theodore S Lawrence; David G Beer; Alnawaz Rehemtulla; Nithya Ramnath; Dipankar Ray
Journal:  J Biol Chem       Date:  2020-03-12       Impact factor: 5.157

4.  Novel patterns of genome rearrangement and their association with survival in breast cancer.

Authors:  James Hicks; Alexander Krasnitz; B Lakshmi; Nicholas E Navin; Michael Riggs; Evan Leibu; Diane Esposito; Joan Alexander; Jen Troge; Vladimir Grubor; Seungtai Yoon; Michael Wigler; Kenny Ye; Anne-Lise Børresen-Dale; Bjørn Naume; Ellen Schlicting; Larry Norton; Torsten Hägerström; Lambert Skoog; Gert Auer; Susanne Månér; Pär Lundin; Anders Zetterberg
Journal:  Genome Res       Date:  2006-12       Impact factor: 9.043

Review 5.  Use of three-dimensional basement membrane cultures to model oncogene-induced changes in mammary epithelial morphogenesis.

Authors:  Kenna R Mills Shaw; Carolyn N Wrobel; Joan S Brugge
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-10       Impact factor: 2.673

6.  Genomic alterations of primary tumor and blood in invasive ductal carcinoma of breast.

Authors:  Ja Seong Bae; Jin Soo Choi; Seung Ho Baik; Woo Chan Park; Byung Joo Song; Jeong Soo Kim; Young Lim; Sang Seol Jung
Journal:  World J Surg Oncol       Date:  2010-04-21       Impact factor: 2.754

Review 7.  Molecular genetic alterations in adrenal and extra-adrenal pheochromocytomas and paragangliomas.

Authors:  Hilde Dannenberg; Paul Komminoth; Winand N M Dinjens; Ernst Jan M Speel; Ronald R de Krijger
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

8.  Genomic signatures of breast cancer metastasis.

Authors:  V Urquidi; S Goodison
Journal:  Cytogenet Genome Res       Date:  2007       Impact factor: 1.636

9.  Robust methods for accurate diagnosis using pan-microbiological oligonucleotide microarrays.

Authors:  Yang Liu; Lee Sam; Jianrong Li; Yves A Lussier
Journal:  BMC Bioinformatics       Date:  2009-02-05       Impact factor: 3.169

10.  Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer.

Authors:  Yang Li; Lihua Zou; Qiyuan Li; Benjamin Haibe-Kains; Ruiyang Tian; Yan Li; Christine Desmedt; Christos Sotiriou; Zoltan Szallasi; J Dirk Iglehart; Andrea L Richardson; Zhigang Charles Wang
Journal:  Nat Med       Date:  2010-01-24       Impact factor: 53.440
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.